Cellyan Biotechnology Co., Ltd SEC filings HKPD

Cellyan Biotechnology Co., Ltd has 67 filings in SEC EDGAR's recent list, going back to Mar 29, 2024. Its latest annual report, Form 20-F, was filed on Aug 7, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 21, 2026. The company's fiscal year ends on March 31.

Cellyan Biotechnology Co., Ltd SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Aug 13, 2026 —
F-3 Shelf registration (foreign issuer) Jun 12, 2026 —
F-1 Registration statement (foreign issuer) Mar 27, 2026 —
424B4 Prospectus Jan 15, 2025 —
F-1/A Amendment no. 3 to form f-1 Dec 10, 2024 —
F-1/A Amendment no. 2 to form f-1 Nov 27, 2024 —
FWP Free writing prospectus Nov 22, 2024 —
F-1/A Amendment no. 1 to form f-1 Nov 21, 2024 —
F-1 Registration statement (foreign issuer) Oct 29, 2024 —

Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
Listed as
HKPD (Nasdaq)
Fiscal year ends
March 31
Incorporated in
Cayman Islands
Headquarters
Kowloon
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
2007702
Former names
Hong Kong Pharma Digital Technology Holdings Ltd (until Dec 17, 2025)

Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.